XML 14 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Sales:        
Sales $ 14,216 $ 7,617 $ 37,939 $ 19,880
Cost of sales:        
Cost of sales 6,597 4,151 17,641 10,101
Gross profit 7,619 3,466 20,298 9,779
Operating expenses:        
Selling, general and administrative expenses 15,221 11,358 40,814 33,349
Research, development and engineering costs, net 4,385 3,136 11,891 10,730
Total operating expenses 19,606 14,494 52,705 44,079
Operating loss (11,987) (11,028) (32,407) (34,300)
Interest expense, net 986 422 2,772 1,190
Other expense, net 11 179 88 499
Loss before provision for income taxes (12,984) (11,629) (35,267) (35,989)
Provision for income taxes (17) 9 11 9
Net loss (12,967) (11,638) (35,278) (35,998)
Other comprehensive gain:        
Unrealized holding gain on investments arising during period 1 2
Other comprehensive gain 1 2
Comprehensive loss $ (12,967) $ (11,638) $ (35,277) $ (35,996)
Basic and diluted net loss per share (in dollars per share) $ (0.87) $ (1.09) $ (2.55) $ (3.43)
Basic and diluted weighted average shares outstanding (in shares) 14,840 10,697 13,852 10,497
Product [Member]        
Sales:        
Sales $ 13,813 $ 7,431 $ 36,686 $ 18,684
Cost of sales:        
Cost of sales 6,361 4,019 16,577 9,393
Service [Member]        
Sales:        
Sales 403 186 1,253 1,196
Cost of sales:        
Cost of sales $ 236 $ 132 $ 1,064 $ 708